Academic Day Presentations on 15.06.2024 at 8 AM by Department of Transfusion Medicine


Recent Submissions

Now showing 1 - 2 of 2
  • Item
    “Bombay Blood group” sharing the Chitra experience
    (SCTIMST, 2024-06-15) Punkesh Patel
    Blood transfusions are now part of the medical and surgical treatment in today’s patient care. It’s been more than a century back only ABO blood groups were discovered and blood banking started to give crossmatch compatible blood units to the patient in need. Patients with rare blood groups becomes a trouble for clinicians and Transfusion Medicine specialists in getting a compatible blood for them and Bombay blood group phenotype is such an example who can only be transfused with blood from another Bombay phenotype donor. Bombay blood group is a rare autosomal recessive phenotype within the ABO blood group. The estimated prevalence is 1 in 10,000 in India and 1 in 10,000,000 outside of India. First discovered by Dr. Y.M. Bhende, C. K. Deshpande and H.M Bhatia in 1952 at Bombay (now “Mumbai”). These patients can be mistaken with ‘O’ group if not typed with patient’s serum, and may lead to severe hemolytic transfusion reactions. At our Blood Centre we maintain rare donor registry for Bombay blood group donors. Interdepartmental communication between the clinicians and Blood Centre becomes crucial along with adopting the patient blood management and blood conservation techniques.
  • Item
    Autologous Blood Transfusion - The Chitra Experience
    (SCTIMST, 2024-06-15) Angel Mary Sam
    During the COVID-19 pandemic, there was a huge shortage of blood donations in our Blood Centre. To alleviate the crisis, we re-introduced the Autologous Transfusion programme. Autologous transfusion is one in which the donor and recipient of blood is the same individual. This avoids serious adverse effects caused by allogeneic blood transfusion, alleviate blood shortages and save blood resources. We could perform autologous transfusion in patients undergoing neurosurgeries as well as vascular surgeries. Methods such as Pre-deposit Autologous Donation, Acute Normovolemic Hemodilution and Intra-operative Cell Salvage were used according to the case specificity and patient conditions. We found that autologous transfusion is feasible in neurosurgical cases like Meningioma, Schwannoma, AV Malformations and spine surgeries and for vascular surgical cases like abdominal aortic aneurysms and thoracic mass lesions. The requirement of allogeneic blood and blood components intra-operatively can be significantly reduced by autologous blood transfusion. It can be practiced routinely and, is a safe alternative during any shortage or pandemic.